. | Tissue . | . | . | ||
---|---|---|---|---|---|
Neuromodulator . | STG . | SG . | PO . | ||
Amines | |||||
Dopamine* | – | – | + | ||
Peptides | |||||
CabTRP | + | – | – | ||
CCAP | – | – | + | ||
Proctolin | + | + | + | ||
RPCH | + | + | + |
. | Tissue . | . | . | ||
---|---|---|---|---|---|
Neuromodulator . | STG . | SG . | PO . | ||
Amines | |||||
Dopamine* | – | – | + | ||
Peptides | |||||
CabTRP | + | – | – | ||
CCAP | – | – | + | ||
Proctolin | + | + | + | ||
RPCH | + | + | + |
STG, stomatogastric ganglion; SG, sinus gland; PO, pericardial organ;CabTRP, Cancer borealis tachykinin-related peptide; CCAP, crustacean cardioactive peptide; RPCH, red pigment concentrating hormone; +,immunoreactivity present; –, immunoreactivity absent
N⩾3 preparations for each antibody in each tissue
The presence of dopamine was assessed using an antibody to its biosynthetic enzyme tyrosine hydroxylase